![Sankalp Arora: Excited to be presenting longterm follow up results of AZA + RUX in patients with myelofibrosis at ASCO24](https://oncodaily.com/pub/uploads/2024/03/download-21-1-e1711901031415.jpg)
Photo from Sankalp Arora/X
May 25, 2024, 09:12
Sankalp Arora: Excited to be presenting longterm follow up results of AZA + RUX in patients with myelofibrosis at ASCO24
Sankalp Arora, Heme/Onc fellow at MD Anderson Cancer Center, shared on X/Twitter:
“The ASCO24 countdown begins!
Excited to be presenting longterm follow up results of phase 2 clinical trial at MD Anderson Cancer Center evaluating AZA + RUX combination therapy in patients with myelofibrosis.
Source: Sankalp Arora/X
Aug 13, 2024, 19:09